GSK Announces Recipients of Linked by Lupus: Optimal Care Initiative Grants Nearing $1 Million
GlaxoSmithKline PLC (GSK)
US:NYSE Investor Relations:
gsk.com/en-gb/investors
Company Research
Source: Business Wire
Grant funding awarded to support lupus-focused community programs across the United States PHILADELPHIA--(BUSINESS WIRE)--GSK plc (LSE/NYSE: GSK) has announced the recipients of the Linked by Lupus: Optimal Care Initiative grant, awarding nearly $1 million to support national, state, and local non-profit organizations working to improve the lives of people impacted by lupus, including systemic lupus erythematosus (SLE) and lupus nephritis (LN).GSK previously sought proposals for community-driven initiatives aimed at improving earlier diagnosis and recognition of lupus signs and symptoms; enhancing awareness of and access to evidence-based treatment options; and/or advancing communication between patients and providers regarding lupus.“We’re proud to support these organizations that are deeply embedded in their communities and uniquely positioned to drive meaningful change,” Court Horncastle, Senior Vice President at GSK, said. “Their work is essential to improving the lupus journey
Show less
Read more
Impact Snapshot
Event Time:
GSK
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GSK alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GSK alerts
High impacting GlaxoSmithKline PLC news events
Weekly update
A roundup of the hottest topics
GSK
News
- GSK (NYSE:GSK) had its "hold" rating reaffirmed by analysts at Deutsche Bank Aktiengesellschaft.MarketBeat
- GSK (NYSE:GSK) had its "underweight" rating reaffirmed by analysts at Morgan Stanley.MarketBeat
- Jefferies Reaffirms a Buy Rating on GSK plc (GSK) – Here's Why [Yahoo! Finance]Yahoo! Finance
- GSK (NYSE:GSK) was downgraded by analysts at Barclays PLC from an "equal weight" rating to an "underweight" rating.MarketBeat
- Why is GSK plc (GSK) One of the Best Affordable Healthcare Stocks to Buy Now? [Yahoo! Finance]Yahoo! Finance
GSK
Sec Filings
- 1/20/26 - Form 6-K
- 1/20/26 - Form 6-K
- 1/16/26 - Form 6-K
- GSK's page on the SEC website